22.08.2023 - Los Angeles, CA, Aug. 22, 2023 (GLOBE NEWSWIRE) - Endonovo Therapeutics, Inc. (OTCQB: ENDV) - a US-based commercial medical device company - today announced its inclusion on the Federal Supply Schedule (FSS) for SofPulse Pulsed Electro Magnetic . Seite 1
02.05.2023 - Los Angeles, CA, May 02, 2023 (GLOBE NEWSWIRE) - Endonovo Therapeutics, Inc. (OTCQB: ENDV) a US-based biotechnology developer, today announced the launch of SofPulse with Academy Medical, Inc., a Service-Disabled Veteran-Owned Small Business . Seite 1
25.04.2023 - Los Angeles, CA, April 25, 2023 (GLOBE NEWSWIRE) - Endonovo Therapeutics, Inc. (OTCQB: ENDV), a leading developer of medical technologies, today announced it is moving forward in its clinical development in the field of Traumatic Brain Injury . Seite 1